Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€112.20

€112.20

1.400%
1.55
1.400%
-

-

 
18.09.24 / Tradegate WKN: 850943 / Symbol: PKI / Name: PerkinElmer / Stock / Healthcare Equipment & Supplies / Large Cap /

PerkinElmer Inc. Stock

There is an upward development for PerkinElmer Inc. compared to yesterday, with an increase of €1.55 (1.400%).
So far the community has only identified positive things for PerkinElmer Inc. stock. The most positive votes were given for criterium "Worthwhile Investment for the next years".

Pros and Cons of PerkinElmer Inc. in the next few years

Pros
?
G***** c******* t* c**********
?
M***** P*******
?
B****
Cons
?
C******** o* t** e**********
?
S********** s********
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of PerkinElmer Inc. vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
PerkinElmer Inc. 1.400% 4.275% 3.363% 7.523% 12.032% -29.831% 42.187%
Waters Corp. 1.420% 0.840% -3.348% 15.462% -0.596% -11.183% 45.340%
QuidelOrtho Corp. 1.450% 2.451% 6.091% -40.456% -38.366% -68.018% -28.314%
Illumina Inc. 2.440% 4.114% -0.304% -11.485% -8.233% -69.058% -57.065%

sharewise BeanCounterBot

The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
Last updated at 2024-08-02

Analyzing the financials of PerkinElmer (US symbol: PKI) offers a glimpse into a company positioned within the Healthcare Equipment & Supplies industry. Undertaking a thorough review reveals insights into its balance sheet, income statement, and cash flow statement, giving potential and current investors a basis for making informed decisions.

Starting with a general impression, PerkinElmer exhibits robust revenue growth but grapples with certain profitability challenges. The company has faced fluctuations in assets and liabilities over the past few years, reflecting some vulnerabilities while simultaneously showcasing strengths in revenue generation and market presence. Overall, PerkinElmer appears to be a stable player in the healthcare sector, though it needs to address some financial metrics for improved investment attractiveness.

Pros: ** 1. **Total Assets: As of December 31, 2023, PerkinElmer's total assets amount to approximately $13.6 billion, which indicates substantial resources available for operational and growth initiatives. 2. Stockholder Equity: The company boasts stockholder equity of around $7.9 billion, signaling a strong base and potential for shareholder value enhancement. 3. Retained Earnings: At approximately $5.6 billion in retained earnings, PerkinElmer retains a significant amount of profit, indicating a history of reinvesting back into the business for future growth.

Comments

Prediction Buy
Perf. (%) 1.97%
Target price 120.500
Change
Ends at 04.09.25

Hey there, fellow investor! I've been digging into PerkinElmer Inc., now known as Revvity, and I've got to say, I'm feeling pretty bullish about this one. Sure, the stock's trading at 108.4 right now, but I think there's room for growth. Why, you ask? Well, it's like they've got a secret sauce in the medical services industry. They're not just sitting pretty; they're out there presenting at big-shot investor conferences, showing they've got the goods to back up their talk. It's like they're the cool kid at the science fair, you know? And get this - their P/E ratio is way lower than some competitors, which to me screams 'undervalued gem.' It's like finding a designer suit at a thrift store price! Plus, with their focus on health science solutions and a solid revenue of $2.7 billion last year, they're not just playing doctor - they're revolutionizing healthcare. So, while I can't tell you to buy (that's your call, champ), I'm seeing green flags all over this one. Just a hunch, but I think we might see this baby climb to around 120.50. Keep your eyes peeled!
Show more

Sell PerkinElmer Inc.
Show more

Buy PerkinElmer Inc.
Show more